Pharmaids Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE117D01018
  • NSEID:
  • BSEID: 524572
INR
51.20
-0.33 (-0.64%)
BSENSE

Dec 05

BSE+NSE Vol: 339

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Pharmaids Pharmaceuticals Ltd stock-summary
stock-summary
Pharmaids Pharmaceuticals Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Pharmaids Pharmaceuticals Limited, incorporated in March, 1989 at Hyderabad, Telangana are the suppliers of Quality Grade range of speciality chemicals, skin care, hospital care and generic products in the areas of Orthopedic, Neuro and Gastro etc. The technical team uses quality proven chemical compounds and standard processing methods maintaining proper hygiene standards.
Company Coordinates stock-summary
Company Details
4-4-211/212/3 1st Floor, Inderbagh Sulthan Bazar Hyderabad Telangana : 500095
stock-summary
Tel: 91-40-66669809
stock-summary
mailpharmaids@yahoo.co.in
Registrar Details
Venture Capital & Corporate Investments Ltd , 12-10-167,, MIG- 167,, Bharat Nagar Colony, Hyderabad
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 35.27 Cr
Number of Shares
3.53 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
02-Mar-2024
3.53
35.27
12856578
10
Preferential basis
06-Jan-2024
2.24
22.41
925000
10
Conversion of Warrants
17-Jan-2023
2.15
21.49
8400000
10
Preferential basis
27-Nov-2019
1.03
10.31
6905734
10
Scheme of Amalgamation
27-Nov-2019
1.03
10.31
6905734
10
Scheme of Amalgamation
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Shankarappa Nagaraja Vinaya Babu (28.52%)

Highest Public shareholder

Shreedhara Shetty (14.53%)

Individual Investors Holdings

47.02%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
Venu Madhava Kaparthy
E D & Wholetime Director
27.0 lacs
Mini Manikantan
E D & Wholetime Director
16.65 lacs
Sadhanala Venkata Rao
Non-Exec & Non-Independent Dir
0
P N Vijay
Independent Non Exe. Director
2.09 lacs
M Sudheer Anand
Independent Non Exe. Director
0
Methuku Nagesh
Independent Non Exe. Director
1.69 lacs
Shreedhara Shetty
Additional Director
0
Sadhanala Venkata Rao
Non Executive Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Capsules (Allopathic Formulation) - Traded
0.93
74.89%
Tablets (Allopathic Formulation)
0.30
24.14%
Capsules (Allopathic Formulation)
0.01
0.97%
 
74.89
Capsules (Allopathic Formulation) - Traded
25.11
Capsules (Allopathic Formulation) - Traded
24.14
Tablets (Allopathic Formulation)
75.86
Tablets (Allopathic Formulation)
0.97
Capsules (Allopathic Formulation)
99.03
Capsules (Allopathic Formulation)
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
9 Cr
(Quarterly Results - Sep 2025)
Net Profit:
-2 Cr
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 183 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

34

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.38

stock-summary
Return on Equity

-31.39%

stock-summary
Price to Book

3.53